merck-kgaa - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,833 +0.73%

DJIA 48,280 +0.77%

Nasdaq 25,073 +0.72%

DAX 23,901 -0.26%

Gold $4,196 +0.16%

Oil $98.10 +1.46%

BTC $72,062 +0.97%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,217 +0.37%

S&P 500 6,833 +0.73%

DJIA 48,280 +0.77%

Nasdaq 25,073 +0.72%

DAX 23,901 -0.26%

Gold $4,196 +0.16%

Oil $98.10 +1.46%

BTC $72,062 +0.97%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,217 +0.37%

merck-kgaa

Mavenclad packs under dramatic light symbolizing Merck KGaA Forecast pressure from 2026 patent expiry

Pharma & Healthcare·Stocks·USA

Merck KGaA Forecast Warning: 2026 Profit Hit Looms

By Maik Kemper • Mar 5, 2026

Mavenclad packs under dramatic light symbolizing Merck KGaA Forecast pressure from 2026 patent expiry

Pharma & Healthcare·Stocks·USA

Merck KGaA Forecast Warning: 2026 Profit Hit Looms

By Maik Kemper • Mar 5, 2026

Is the latest Merck KGaA Forecast a temporary setback before new growth, or the start of a longer earnings squeeze? Merck KGaA Forecast: What the…